Agilent Technologies [A] vs Thermo Fisher [TMO] Detailed Stock Comparison
Agilent Technologies
NYSE
Loading...
Thermo Fisher
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Agilent Technologies wins in 10 metrics, Thermo Fisher wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | Agilent Technologies | Thermo Fisher | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 28.81 | 26.89 | Thermo Fisher |
| Price-to-Book Ratio | 6.17 | 3.63 | Thermo Fisher |
| Debt-to-Equity Ratio | 56.42 | 69.62 | Agilent Technologies |
| PEG Ratio | 1.33 | 4.73 | Agilent Technologies |
| EV/EBITDA | 22.50 | 19.60 | Thermo Fisher |
| Profit Margin (TTM) | 17.97% | 15.24% | Agilent Technologies |
| Operating Margin (TTM) | 23.19% | 17.84% | Agilent Technologies |
| EBITDA Margin (TTM) | 23.19% | 17.84% | Agilent Technologies |
| Return on Equity | 19.88% | 13.42% | Agilent Technologies |
| Return on Assets (TTM) | 8.35% | 4.97% | Agilent Technologies |
| Free Cash Flow (TTM) | $1.37B | $7.27B | Thermo Fisher |
| Dividend Yield | 0.85% | 0.31% | Agilent Technologies |
| 1-Year Return | -4.33% | -12.30% | Agilent Technologies |
| Price-to-Sales Ratio (TTM) | 5.79 | 4.24 | Thermo Fisher |
| Enterprise Value | $41.35B | $212.08B | Thermo Fisher |
| EV/Revenue Ratio | 6.09 | 4.91 | Thermo Fisher |
| Gross Profit Margin (TTM) | 51.09% | 40.61% | Agilent Technologies |
| Revenue per Share (TTM) | $24 | $114 | Thermo Fisher |
| Earnings per Share (Diluted) | $4.81 | $18.04 | Thermo Fisher |
| Beta (Stock Volatility) | 1.26 | 0.76 | Thermo Fisher |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Agilent Technologies vs Thermo Fisher Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Agilent Technologies | 0.09% | 13.79% | 10.77% | 14.95% | 19.58% | 3.95% |
| Thermo Fisher | -1.09% | 14.32% | 7.68% | 22.72% | 7.34% | 0.46% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Agilent Technologies | -4.33% | 8.84% | 31.15% | 282.83% | 473.61% | 509.67% |
| Thermo Fisher | -12.30% | 0.26% | 12.97% | 314.92% | 1,006.11% | 1,622.87% |
News Based Sentiment: Agilent Technologies vs Thermo Fisher
Agilent Technologies
News based Sentiment: POSITIVE
Agilent reported strong financial results, launched new products, and received positive analyst attention, culminating in inclusion in the MOAT ETF. While competitive pressures exist, the overall narrative is one of positive momentum and growth potential, making this a significant month for the company.
Thermo Fisher
News based Sentiment: POSITIVE
October 2025 was a demonstrably positive month for Thermo Fisher Scientific, characterized by a significant stock surge, strategic financial maneuvers, and proactive investments in innovation and customer support. These developments collectively reinforce a strong growth trajectory and positive investor sentiment.
Performance & Financial Health Analysis: Agilent Technologies vs Thermo Fisher
| Metric | A | TMO |
|---|---|---|
| Market Information | ||
| Market Cap | $39.32B | $201.36B |
| Market Cap Category | Large cap | Mega cap |
| 10 Day Avg. Volume | 1,867,180 | 2,827,260 |
| 90 Day Avg. Volume | 1,862,450 | 1,990,550 |
| Last Close | $138.70 | $524.96 |
| 52 Week Range | $96.43 - $153.84 | $385.46 - $616.57 |
| % from 52W High | -9.84% | -14.86% |
| All-Time High | $179.57 (Aug 30, 2021) | $672.34 (Dec 27, 2021) |
| % from All-Time High | -22.76% | -21.92% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.10% | 0.03% |
| Quarterly Earnings Growth | 0.19% | 0.05% |
| Financial Health | ||
| Profit Margin (TTM) | 0.18% | 0.15% |
| Operating Margin (TTM) | 0.23% | 0.18% |
| Return on Equity (TTM) | 0.20% | 0.13% |
| Debt to Equity (MRQ) | 56.42 | 69.62 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $22.46 | $133.77 |
| Cash per Share (MRQ) | $5.41 | $16.92 |
| Operating Cash Flow (TTM) | $1.50B | $7.58B |
| Levered Free Cash Flow (TTM) | $902.88M | $5.18B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.85% | 0.31% |
| Last 12-Month Dividend | $0.98 | $1.21 |
Valuation & Enterprise Metrics Analysis: Agilent Technologies vs Thermo Fisher
| Metric | A | TMO |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 28.81 | 26.89 |
| Forward P/E | 24.53 | 20.65 |
| PEG Ratio | 1.33 | 4.73 |
| Price to Sales (TTM) | 5.79 | 4.24 |
| Price to Book (MRQ) | 6.17 | 3.63 |
| Market Capitalization | ||
| Market Capitalization | $39.32B | $201.36B |
| Enterprise Value | $41.35B | $212.08B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 6.09 | 4.91 |
| Enterprise to EBITDA | 22.50 | 19.60 |
| Risk & Other Metrics | ||
| Beta | 1.26 | 0.76 |
| Book Value per Share (MRQ) | $22.46 | $133.77 |
Financial Statements Comparison: Agilent Technologies vs Thermo Fisher
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | A | TMO |
|---|---|---|
| Revenue/Sales | $1.67B | $10.36B |
| Cost of Goods Sold | $802.00M | $6.13B |
| Gross Profit | $866.00M | $4.24B |
| Research & Development | $112.00M | $342.00M |
| Operating Income (EBIT) | $300.00M | $1.82B |
| EBITDA | $362.00M | $2.73B |
| Pre-Tax Income | $260.00M | $1.62B |
| Income Tax | $45.00M | $95.00M |
| Net Income (Profit) | $215.00M | $1.51B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | A | TMO |
|---|---|---|
| Cash & Equivalents | $1.49B | $4.13B |
| Total Current Assets | $4.21B | $23.38B |
| Total Current Liabilities | $2.01B | $13.17B |
| Long-Term Debt | $3.35B | $31.37B |
| Total Shareholders Equity | $6.14B | $49.49B |
| Retained Earnings | $912.00M | $54.45B |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | A | TMO |
|---|---|---|
| Operating Cash Flow | $178.00M | $2.15B |
| Capital Expenditures | $-114.00M | $-350.00M |
| Free Cash Flow | $107.00M | $361.00M |
| Debt Repayment | $0 | $-838.00M |
| Common Stock Repurchase | $-165.00M | $-2.00B |
Short Interest & Institutional Ownership Analysis
| Metric | A | TMO |
|---|---|---|
| Shares Short | 3.20M | 3.83M |
| Short Ratio | 1.81 | 2.34 |
| Short % of Float | 0.01% | 0.01% |
| Average Daily Volume (10 Day) | 1,867,180 | 2,827,260 |
| Average Daily Volume (90 Day) | 1,862,450 | 1,990,550 |
| Shares Outstanding | 285.19M | 380.77M |
| Float Shares | 282.49M | 376.74M |
| % Held by Insiders | 0.00% | 0.00% |
| % Held by Institutions | 0.93% | 0.92% |
Dividend Analysis & Yield Comparison: Agilent Technologies vs Thermo Fisher
| Metric | A | TMO |
|---|---|---|
| Last 12-Month Dividend | $0.98 | $1.21 |
| Last 12-Month Dividend Yield | 0.85% | 0.31% |
| 3-Year Avg Annual Dividend | $0.86 | $1.33 |
| 3-Year Avg Dividend Yield | 0.18% | 0.07% |
| 3-Year Total Dividends | $2.57 | $3.99 |
| Ex-Dividend Date | Apr 01, 2025 | Mar 14, 2025 |